BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare PartnershipProof-of-Concept Trial Opens Door to 90+ Million Population Across North Africa and Francophone MarketsAugust 12, 2025 8:30 AM EDT | Source: BioMark Diagnostics, Inc.Vancouver, British Columbia--(Newsfile Corp. - August 12, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early cancer detection, announced today ...